October 2009 Issue of MMM
If you want to see something really ugly, then you need look no further than the journal advertising numbers for the first half of 2009.
Pharma companies like Novo Nordisk are finding success by reaching out to existing patient communities. Ben Comer looks at the latest trends
Medical/surgical journals have seen better days but there is a silver lining in the sector that has been hit hard the past few years. Anthony ...
Pharmaceutical marketers increasingly have a difficult time trying to gain 'share of voice' with physicians, with fewer reps granted access. How can branded and unbranded ...
Fresh approaches to observational research can uncover the causes of poor adherence, says Laura Winn Johnson
Bob Pearson doesn't want to hear any more excuses for poor or non-existent social media programs from healthcare companies.
The rapid growth of social media is fundamentally changing how pharma brands communicate with their target audiences. Now, brands not only talk to customers, customers ...
The day will come soon when all flu vaccines are grown in cell culture, using genetic splicing techniques to provoke and immunologic (antibody) response rather ...
Pfizer had to cough up $2.3 billion in September, as part of a fraud settlement to resolve criminal and civil liability charges arising from the ...
Roska Healthcare has developed a non-personal promotion (NPP) strategy for Cephalon's skeletal muscle relaxant, Amrix.
According to data from a white paper by Manhattan Research, the average physician spends a full work day [about eight hours] each week using the ...
Featuring news about Baxter Healthcare, Purohit Navigation, Cegedim Dendrite and Boehringer Ingelheim
In just over a month, the American Medical Association (AMA) has launched a YouTube channel, a blog written by AMA president James Rohack and a ...
Wolters Kluwer Health launched a software platform for nurses, pharmacists, therapists and other caregivers to provide clinical decision support at the point of care.
Most patients get a second opinion online before filling a script or continuing therapy. What are some of the most effective ways to reach patients ...
WebMD and the FDA will roll out the second phase of their partnership this fall with the addition of five condition-specific online FDA centers.
Boehringer Ingelheim launched new YouTube videos and a channel devoted to Parkinson's disease, while the company's US operations launched a Twitter feed, following its German ...
Featuring news about Everyday Health, FDA, Twitter, Stanford University School of Medicine, University of Philadelphia and the Cleveland Clinic
Even though DTC is a relatively new phenomenon, it has two pioneering grandpas who are still going strong...and have much to teach the young whippersnappers ...
Allergan is tweaking two teen cultural sensations with a High School Musical-themed interactive campaign for its acne medication Aczone, starring Michael Welch of Twilight fame.
Merck bolstered its HIV/AIDS education effort with a new online video series starring Jack Mackenroth of Project Runway.
GlaxoSmithKline recruited tennis great John McEnroe for an awareness campaign about prostate cancer.
Americans blame health insurance companies more than pharmas for problems with the US healthcare system—but not by much.
Featuring news about UCB, Sanofi-Aventis, PhRMA and AstraZeneca
WPP formally launched KantarHealth, an amalgam of four companies that bundles global research with consulting capabilities.
GfK Healthcare launched a new product to provide pharma marketers with the ability to access and query a panel of managed market workers representing the ...
Feguson, a CommonHealth professional shop, launched a new "OTC Center of Excellence" focused on OTC marketing and promotion.
Spectrum, a founding partner of GlobalHealthPR, an international communications network, added two new employees at its Washington DC headquarters.
Featuring news about Palio, Zemoga, MicroMass, Worldwide Partners, Inc. (WPI) and Merkle
Until earlier this year, most drug manufacturers had been operating under the same policy relating to the use of sponsored links on search engines as ...
Stanford University researchers say that drug labeling would be much more informative for doctors and patients if it had to include comparative effectiveness information.
Two industry groups, one representing health communicators and the other medical device makers, have sharply criticized a draft FDA guidance on how to present risk ...
Strange how some bad ideas have a way of sticking around. Commercials in movie theaters, the cellophane they use to imprison DVDs and, in pharmaceutical ...
After widespread press coverage of "death panels" and boisterous August town halls, many Americans might well be wondering if it's déjà vu all over again—will ...
In its August 2009 blizzard of compliance correspondence, DDMAC used some of the harshest language in recent Warning Letter memory to send what can only ...
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.